A platform technology for generating subunit vaccines against diverse viral pathogens
The COVID-19 pandemic response has shown how vaccine platform technologies can be
used to rapidly and effectively counteract a novel emerging infectious disease. The speed of
development for mRNA and vector-based vaccines outpaced those of subunit vaccines,
however, subunit vaccines can offer advantages in terms of safety and stability. Here we
describe a subunit vaccine platform technology, the molecular clamp, in application to four
viruses from divergent taxonomic families: Middle Eastern respiratory syndrome coronavirus …
used to rapidly and effectively counteract a novel emerging infectious disease. The speed of
development for mRNA and vector-based vaccines outpaced those of subunit vaccines,
however, subunit vaccines can offer advantages in terms of safety and stability. Here we
describe a subunit vaccine platform technology, the molecular clamp, in application to four
viruses from divergent taxonomic families: Middle Eastern respiratory syndrome coronavirus …
以上显示的是最相近的搜索结果。 查看全部搜索结果